Profile of consultations and medical prescriptions throughout the COVID-19 pandemic at CAPS-AD

Perfil de consultas e prescrições médicas ao longo da pandemia da COVID-19 no CAPS-AD

Authors

DOI:

https://doi.org/10.17765/2176-9206.2025v18e12856

Keywords:

COVID-19, Psychotropic Drugs, SARS-CoV-2, Therapeutic Adherence

Abstract

The COVID-19 pandemic has increased anxiety and depression, leading to a rise in demand for mental health services such as CAPS-AD. This study analyzed the impact of the pandemic on the CAPS-AD (Alcohol and Drug Mental Health Services) in Paulo Afonso, Bahia, using secondary data from patient records between January 2019 and January 2022, along with the Chi-square statistical test. The sample included 173 patients, predominantly males (89.5%), aged between 25 and 60 years (83,3%), single (55,5%), white (46,8%), religious (74%), and with elementary education (54,9%). Alcohol was the most commonly used substance (89%), followed by tobacco (46.8%) and marijuana (27.7%). Most patients showed worsening in substance dependence. The pandemic exacerbated mental disorders, reflected in increased consultations at the CAPS-AD. The results emphasize the need for preventive approaches in mental health, considering the diverse profiles of CAPS-AD users and the impacts of the pandemic. This analysis can inform effective interventions and more comprehensive care strategies.

Downloads

Download data is not yet available.

Author Biographies

João Vítor Bezerra Firmiano, Federal University of the São Francisco Valley

Student, Medical College, Federal University of the São Francisco Valley (Univasf), Paulo Afonso (BA), Brazil

José Matheus Mendonça da Silva, Federal University of the São Francisco Valley

Student, Medical College, Federal University of the São Francisco Valley (Univasf), Paulo Afonso (BA), Brazil

Anekécia Lauro da Silva, Federal University of the São Francisco Valley

Professor, Medical College, Federal University of the São Francisco Valley (Univasf), Paulo Afonso (BA), Brazil

Matheus Rodrigues Lopes, Federal University of the São Francisco Valley

Professor, Medical College, Federal University of the São Francisco Valley (Univasf), Paulo Afonso (BA), Brazil

Diogo Vilar da Fonsêca, Federal University of the São Francisco Valley

Graduated in Pharmacy from the Federal University of Paraíba, where he trained in Clinical Analysis, master's and doctorate in Natural and Synthetic Bioactive Products and post-doctorate in Biotechnology from the Postgraduate Program in Development and Technological Innovation in Medicines. Specialized in Hospital Pharmacy and also in Pharmacology and Pharmaceutical Dispensing from Faculdades Cathedral de Ensino Superior. Currently, he is a professor at UNIVASF, Paulo Afonso campus (Bahia) and is part of the permanent staff of the Postgraduate Program in Bioscience at the same institution. He works in the area of ​​experimental research of new drugs for the treatment of pain, inflammation and convulsions.

References

BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Ações Programáticas Estratégicas. Saúde mental no SUS: os centros de atenção psicossocial. 1. ed. Brasília: Ministério da Saúde; 2004. Disponível em: http://www.ccs.saude.gov.br/saude_mental/pdf/sm_sus.pdf. Acesso em: 15 jan, 2022.

BRASIL. Ministério da Saúde. PORTARIA Nº 3.088, DE 23 DE DEZEMBRO DE 2011. Institui a Rede de Atenção Psicossocial para pessoas com sofrimento ou transtorno mental e com necessidades decorrentes do uso de crack, álcool e outras drogas, no âmbito do Sistema Único de Saúde (SUS). 26 de dezembro, 2011. Disponível em: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt3088_23_12_2011_rep.html. Acesso em: 15 jan, 2022.

Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, et al. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatry. 2021;11(7):347-354. https://doi.org/10.5498/wjp.v11.i7.347

Souza ASR, Souza GFA, Souza GA, Cordeiro ALN, Praciano GAF, Alves AC de S, et al. Factors associated with stress, anxiety, and depression during social distancing in Brazil. Rev Saúde Pública [Internet]. 2021;55:5. Available from: https://doi.org/10.11606/s1518-8787.2021055003152

de Moura PT, Rockenbach CA, Mendes C da R, Mendes GU, Ghiggi LA, Diel M, et al. Depression and suicide risk during the Covid-19 pandemic at a Brazilian public health psychosocial addiction care center: a preliminary report. Trends Psychiatry Psychother [Internet]. 2022;44:e20210259. Available from: https://doi.org/10.47626/2237-6089-2021-0259

Luykx JJ, van Veen SMP, Risselada A, Naarding P, Tijdink JK, Vinkers CH. Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic. Br J Psychiatry. 2020;217(3):471-474. https://doi.org/10.1192/bjp.2020.92

Musse FCC, Castro LS, Mestre TF, Pelloso SM, Poyares D, Musse JLL, et al. Violência mental: ansiedade e depressão durante a pandemia de COVID-19 no Brasil. Saúde Pesqui. 2022;15(1):1-11. https://doi.org/10.17765/2176-9206.2022v15n1.e9684

Patel R, Irving J, Brinn A, Broadbent M, Shetty H, Pritchard M, et al. Impact of the COVID-19 pandemic on remote mental healthcare and prescribing in psychiatry: an electronic health record study. BMJ Open. 2021;11(3):e046365. https://doi.org/10.1136/bmjopen-2020-046365

Šljivo A, Kačamaković M, Quraishi I, Džubur Kulenović A. Fear and Depression among Residents of Bosnia and Herzegovina during COVID-19 Outbreak - Internet Survey. Psychiatr Danub. 2020;32(2):266-272. https://doi.org/10.24869/psyd.2020.266

Shi L, Lu ZA, Que JY, Huang XL, Liu L, Ran MS, et al. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014053. https://doi.org/10.1001/jamanetworkopen.2020.14053

Gualano MR, Lo Moro G, Voglino G, Bert F, Siliquini R. Effects of Covid-19 Lockdown on Mental Health and Sleep Disturbances in Italy. Int J Environ Res Public Health. 2020;17(13):4779. https://doi.org/10.3390/ijerph17134779

De Oliveira VC, Capistrano FC, Ferreira ACZ, Kalinke LP, Felix JVC, Maftum MA. Perfil sociodemográfico e clínico de pessoas atendidas em um CAPS AD do sul do Brasil. Rev. Baiana Enferm. [Internet]. 30º de março de 2017 [citado 10 de julho de 2023];31(1). Disponível em: https://doi.org/10.18471/rbe.v31i1.16350

Santana GV, Santos JL, Santos JM de J, Alves LJ, Menezes AF de, Freitas CKAC. Perfil sociodemográfico e de dependência química dos usuários de um Centro de Atenção Psicossocial especializado. SMAD Rev Eletr Saúde Mental Álcool Drog. 2021;17(4):7-13. https://dx.doi.org/10.11606/issn.1806-6976.smad.2021.155433

Galloni L, de Freitas LR, Vieira Gonzaga R. Consumo de psicoativos lícitos durante a pandemia de Covid-19. Rev Bras Ciênc Bioméd. 2021;2(1):e0442021-1/8. https://doi.org/10.46675/rbcbm.v2i1.44

World Health Organization. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. Geneva: World Health Organization; 2023. Disponível em: https://www.who.int/publications-detail-redirect/9789240077164. Acesso em: 02 mar, 2024.

de Souza RF, Padula MPC. Condições de pessoas em sofrimento psíquico acompanhadas em Centro de Atenção Psicossocial (CAPS) e internadas em hospitais / Conditions of people in psychological distress supported by a Psychosocial Care Center (CAPS) and admitted to hospitals. Braz. J. Hea. Rev. [Internet]. 2020 Sep. 9 [cited 2023 Jul. 10];3(5):11967-88. Available from: https://doi.org/10.34119/bjhrv3n5-050

Almeida FM, et al. Perfil sociodemográfico e farmacoterapêutico de usuários dos Centros de Atenção Psicossocial III Álcool e Drogas. SMAD Rev Eletr Saúde Mental Álcool Drog (Ed. Port.). 2023;19(2):95-107. https://doi.org/10.11606/issn.1806-6976.smad.2023.201959

Benatto MC, da Silva SM, Johann DA. Perfil de atendimento em Centro de Atenção Psicossocial durante a pandemia da COVID-19: uma análise retrospectiva. Cad Ibero-Am Direito Sanit. 2022;11(2):103-117. https://doi.org/10.17566/ciads.v11i2.893

Barbosa GC, Fernandes IF de AL, Claro HG, Boska GA, Silva JC de MC, Oliveira MA de AF. Preditores de problemas relacionados ao uso de substâncias psicoativas entre usuários em tratamento psicossocial. REME-Rev Min Enferm. 2023;27. https://doi.org/10.35699/2316-9389.2023.41536

Ribeiro JP, Gomes GC, Vicente BG, Soares MC, Braga LR, dos Santos EO. Profile of adolescent user of crack in treatment in the psychosocial care center alcohol and drugs / Perfil do adolescente usuário de crack em tratamento no Centro de Atenção Psicossocial Álcool e Drogas. Rev Pesqui Cuidado é Fundam Online. 2021;13:41-49. https://doi.org/10.9789/2175-5361.rpcfo.v13.7159

Amill-Rosario A, Lee H, Zhang C, dosReis S. Psychotropic Prescriptions During the COVID-19 Pandemic Among U.S. Children and Adolescents Receiving Mental Health Services. J Child Adolesc Psychopharmacol. 2022;32(7):408-414. https://doi.org/10.1089/cap.2022.0037

De Bandt D, Haile SR, Devillers L, Bourrion B, Menges D. Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis. BMJ Ment Health. 2024;27(1):e301026. https://doi.org/10.1136/bmjment-2024-301026

Mattos MP, Campos HMN, Gomes DR, Ferreira L, Carvalho RB de, Esposti CDD. Educação Permanente em Saúde nos Centros de Atenção Psicossocial: revisão integrativa da literatura. Saúde debate [Internet]. 2020Oct;44(127):1277-1299. Available from: https://doi.org/10.1590/0103-1104202012724

Published

2025-04-13

How to Cite

Firmiano, J. V. B. ., da Silva, J. M. M. ., da Silva, A. L. ., Lopes, M. R. ., & Vilar da Fonsêca, D. (2025). Profile of consultations and medical prescriptions throughout the COVID-19 pandemic at CAPS-AD: Perfil de consultas e prescrições médicas ao longo da pandemia da COVID-19 no CAPS-AD. Saúde E Pesquisa, 18, e12856. https://doi.org/10.17765/2176-9206.2025v18e12856

Issue

Section

Artigos Originais